CLINICAL_TRIALS
trial_result
· 2020-11-06
Clinical Trial Update: A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia [Phase 2]
Summary
Phase 2 trial update for AG-86893 in patients with pterygium has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allgenesis Biotherapeutics Inc. | Conditions: Pterygium | Phase 2 | Status: COMPLETED | Results posted: 2020-11-06